22-42126749-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_000106.6(CYP2D6):c.1319G>A(p.Arg440His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000167 in 1,549,504 control chromosomes in the GnomAD database, including 5 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).
Frequency
Genomes: 𝑓 0.00039 ( 0 hom., cov: 30)
Exomes 𝑓: 0.00014 ( 5 hom. )
Consequence
CYP2D6
NM_000106.6 missense
NM_000106.6 missense
Scores
8
11
Clinical Significance
Conservation
PhyloP100: 0.319
Publications
15 publications found
Genes affected
CYP2D6 (HGNC:2625): (cytochrome P450 family 2 subfamily D member 6) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is known to metabolize as many as 25% of commonly prescribed drugs. Its substrates include antidepressants, antipsychotics, analgesics and antitussives, beta adrenergic blocking agents, antiarrythmics and antiemetics. The gene is highly polymorphic in the human population; certain alleles result in the poor metabolizer phenotype, characterized by a decreased ability to metabolize the enzyme's substrates. Some individuals with the poor metabolizer phenotype have no functional protein since they carry 2 null alleles whereas in other individuals the gene is absent. This gene can vary in copy number and individuals with the ultrarapid metabolizer phenotype can have 3 or more active copies of the gene. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2014]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -8 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.06325573).
BS2
High AC in GnomAd4 at 58 AD gene.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000387 AC: 58AN: 150038Hom.: 0 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
58
AN:
150038
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.000219 AC: 32AN: 145816 AF XY: 0.000270 show subpopulations
GnomAD2 exomes
AF:
AC:
32
AN:
145816
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000143 AC: 200AN: 1399352Hom.: 5 Cov.: 38 AF XY: 0.000155 AC XY: 107AN XY: 690498 show subpopulations
GnomAD4 exome
AF:
AC:
200
AN:
1399352
Hom.:
Cov.:
38
AF XY:
AC XY:
107
AN XY:
690498
show subpopulations
African (AFR)
AF:
AC:
3
AN:
31728
American (AMR)
AF:
AC:
22
AN:
35814
Ashkenazi Jewish (ASJ)
AF:
AC:
1
AN:
25162
East Asian (EAS)
AF:
AC:
0
AN:
36104
South Asian (SAS)
AF:
AC:
3
AN:
79326
European-Finnish (FIN)
AF:
AC:
13
AN:
49450
Middle Eastern (MID)
AF:
AC:
2
AN:
4552
European-Non Finnish (NFE)
AF:
AC:
129
AN:
1079286
Other (OTH)
AF:
AC:
27
AN:
57930
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
11
22
34
45
56
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome AF: 0.000386 AC: 58AN: 150152Hom.: 0 Cov.: 30 AF XY: 0.000436 AC XY: 32AN XY: 73326 show subpopulations
GnomAD4 genome
AF:
AC:
58
AN:
150152
Hom.:
Cov.:
30
AF XY:
AC XY:
32
AN XY:
73326
show subpopulations
African (AFR)
AF:
AC:
5
AN:
40464
American (AMR)
AF:
AC:
34
AN:
15126
Ashkenazi Jewish (ASJ)
AF:
AC:
0
AN:
3468
East Asian (EAS)
AF:
AC:
1
AN:
5072
South Asian (SAS)
AF:
AC:
0
AN:
4704
European-Finnish (FIN)
AF:
AC:
0
AN:
10568
Middle Eastern (MID)
AF:
AC:
1
AN:
292
European-Non Finnish (NFE)
AF:
AC:
13
AN:
67488
Other (OTH)
AF:
AC:
4
AN:
2066
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.468
Heterozygous variant carriers
0
4
7
11
14
18
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
Hom.:
Bravo
AF:
ExAC
AF:
AC:
4
ClinVar
Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
not provided Other:1
-
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:drug response
Review Status:no assertion criteria provided
Collection Method:not provided
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
.;.;T;T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M;M;.;.
PhyloP100
PrimateAI
Benign
T
PROVEAN
Uncertain
.;.;D;.;D
REVEL
Uncertain
Sift
Benign
.;.;D;.;T
Sift4G
Uncertain
.;.;D;D;D
Vest4
0.34, 0.37, 0.37
MutPred
Loss of methylation at R440 (P = 0.0071);Loss of methylation at R440 (P = 0.0071);Loss of methylation at R440 (P = 0.0071);.;.;
MVP
0.76
MPC
0.19
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.